Hans Rollema
Neuropharmacology
Hans Rollema
Neuropharmacology
Education: PhD 1976, University of Groningen, The Netherlands
Experience:
1980-1992 Assistant Professor at Pharmacy School, Groningen University (Pharmaceutical Chemistry and Bioanalysis)
1987-1988 Visiting professor at UCSF with Dr. Neal Castagnoli (MPTP studies)
1992-2011 Research scientist at Pfizer (Neuroscience)
2013-present BioPharmaWorks (Pharmacology, Bioanalysis)
Expertise: Pharmaceutical Chemistry, Bioanalysis, Microdialysis
Hans is a pharmacologist with 12 years of experience in academia and 19 years in discovery at Pfizer. He has extensive experience in neuropharmacology and in vivo bioanalysis. At Pfizer his microdialysis lab supported several neuroscience projects with neurotransmitter and PK data. He was a member of Chantix (varenicline) discovery and development teams and continued for a few years as a varenicline consultant for Pfizer after retiring. He is a (co)author of over 100 publications and have given several presentations at international conferences. At BioPharmaWorks he participates in projects that require pharmacological and bioanalytical support by designing, outsourcing and managing experiments conducted by CROs.
Education: PhD 1976, University of Groningen, The Netherlands
Experience:
1980-1992 Assistant Professor at Pharmacy School, Groningen University (Pharmaceutical Chemistry and Bioanalysis)
1987-1988 Visiting professor at UCSF with Dr. Neal Castagnoli (MPTP studies)
1992-2011 Research scientist at Pfizer (Neuroscience)
2013-present BioPharmaWorks (Pharmacology, Bioanalysis)
Expertise: Pharmaceutical Chemistry, Bioanalysis, Microdialysis
Hans is a pharmacologist with 12 years of experience in academia and 19 years in discovery at Pfizer. He has extensive experience in neuropharmacology and in vivo bioanalysis. At Pfizer his microdialysis lab supported several neuroscience projects with neurotransmitter and PK data. He was a member of Chantix (varenicline) discovery and development teams and continued for a few years as a varenicline consultant for Pfizer after retiring. He is a (co)author of over 100 publications and have given several presentations at international conferences. At BioPharmaWorks he participates in projects that require pharmacological and bioanalytical support by designing, outsourcing and managing experiments conducted by CROs.